Clinical trial Recruiting at 5 sites Observational Ages 18 to 50

Investigation of selective fetal growth restriction in monochorionic twins

Official title: Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation

Run by Leiden University Medical Center · NCT05952583 · Data updated 2026-11-12

This study is trying to find better ways to understand and manage growth problems in one twin of monochorionic twins during pregnancy, while also checking how these issues affect the twins' development later on.

More Twin trials

Quick facts

Study typeObservational
Ages18 Years to 50 Years
SexAll
Enrollment274 (estimated)
SponsorLeiden University Medical Center
Academic / other
Locations6 sites (Boston, Massachusetts and 5 other locations)
StatusRecruiting
StartedFebruary 17, 2023
Main results expectedMarch 1, 2025
Study endsMarch 1, 2028
Registry record updatedApril 15, 2024
Trial IDNCT05952583 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include pregnant women with monochorionic diamniotic twin pregnancies diagnosed with sFGR before 28 weeks of gestation.

Probably not a fit

Patients with lethal anomalies in one or both fetuses or those with higher-order multiple pregnancies will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to improve the diagnostic management and understanding of selective fetal growth restriction (sFGR) in monochorionic diamniotic twin pregnancies. It focuses on identifying predictors of fetal deterioration and enhancing the current classification system based on umbilical artery flow patterns. The study will also involve extensive histological examinations of the placenta and assess neurodevelopment outcomes of affected twins at two years of age. By addressing these challenges, the study seeks to provide better counseling and management strategies for parents during pregnancy.

Why it matters

Potential benefit: If successful, this study could lead to improved prediction of fetal outcomes and better management of pregnancies affected by selective fetal growth restriction.

How similar studies have gone: While the approach to improving diagnostic management of sFGR is novel, similar studies have shown promise in enhancing outcome prediction in twin pregnancies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* MCDA twin pregnancy
* Diagnosis of sFGR before 28+0 weeks of GA (independent of Doppler flows)
* Pregnant woman ≥ 18 years and able to consent
* Partner (who has (future) parental responsibility - if applicable) ≥ 18 years and able to consent
* Written informed consent of both parents (if applicable) for participation in the longitudinal follow-up until 2 years after birth)

Exclusion Criteria:

* The presence of lethal anomalies (one or both fetuses)
* Multiple pregnancy higher order than twins;
* TTTS/TAPS present at moment of sFGR diagnosis.

Where it's running

  • Boston Children's Hospital
    Boston, Massachusetts, United States
    Recruiting
  • Universitaire Ziekenhuizen Leuven
    Leuven, Belgium
    Recruiting
  • Mount Sinai Hospital
    Toronto, Ontario, Canada
    Recruiting
  • Leiden University Medical Center
    Leiden, South Holland, Netherlands
    Recruiting
  • BCNatal
    Barcelona, Spain
    Recruiting
  • Karolinska University Hospital
    Stockholm, Sweden
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Preeclampsia Biomarker Test in African Women

    This study tests whether measuring the sFlt-1/PlGF ratio using quick clinic tests helps predict which pregnant women in Africa will develop severe preeclampsia.

    Recruiting Africa Clinical Research Network (ACRN) · Harare, Harare · NCT07810439

  • New sensor for monitoring fetal health during late pregnancy

    This study is testing a new non-adhesive sensor to see if it can accurately monitor the heart rates of pregnant women and their babies during late pregnancy.

    Recruiting University of Manchester · Manchester · NCT06952777

  • Study of Twin Pregnancies and Their Outcomes in China

    This study is trying to understand the challenges and outcomes of twin pregnancies in China by following 2000 pregnant women and their babies from pregnancy through early childhood.

    Recruiting at 11 sites Peking University Third Hospital · Hefei, Anhui and 10 other locations · NCT06414655

  • STV analysis for fetal monitoring in severe early FGR

    Researchers are testing whether short-term variation (STV) analysis of fetal monitoring helps improve perinatal survival for pregnant people with severe early fetal growth restriction compared with traditional visual CTG interpretation.

    Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Groningen, Provincie Groningen and 5 other locations · NCT06010238

  • Understanding the challenges of twin pregnancies

    This study looks at the challenges and health risks faced by mothers and babies during twin pregnancies to help improve care and support for families.

    Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome · NCT05761769

  • Using melatonin to protect the brain in pregnancies with fetal growth restriction

    This study is testing if giving melatonin to pregnant women with severe fetal growth restriction can help improve their baby's health and protect against brain injury before birth.

    Recruiting at 12 sites Phase 3 Monash University · Camperdown, New South Wales and 11 other locations · NCT05651347

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.